Ratings by B.Riley (William Wood)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/5/2026 | iBio, Inc. | IBIO | New Coverage | Buy (N/A) |
1.93 (1.38) |
-28.5% | Details | |
| 5/22/2026 | Immunic Inc. | IMUX | Maintain | Buy (N/A) |
|
Details | ||
| 5/15/2026 | Aardvark Therapeutics Inc | AARD | Maintain | Buy (N/A) |
|
Details | ||
| 4/16/2026 | Equillium | EQ | New Coverage | Buy (N/A) |
2.05 (2.59) |
26.34% | Details | |
| 3/24/2026 | Aardvark Therapeutics Inc | AARD | Maintain | Buy (N/A) |
|
Details | ||
| 1/28/2026 | Aardvark Therapeutics Inc | AARD | New Coverage | Buy (N/A) |
14.76 (5.86) |
-60.3% | Details | |
| 1/9/2026 | Palisade Bio Inc. | PALI | New Coverage | Buy (N/A) |
2.02 (1.97) |
-2.48% | Details | |
| 12/7/2025 | OKYO Pharma Ltd. | OKYO | New Coverage | Buy (N/A) |
2.01 (1.43) |
-28.86% | Details | |
| 9/2/2025 | Immunic Inc. | IMUX | Maintain | Buy (N/A) |
|
Details | ||
| 5/23/2025 | Immunic Inc. | IMUX | Maintain | Buy (N/A) |
|
Details | ||
| 8/27/2024 | Immunic Inc. | IMUX | New Coverage | Buy (N/A) |
1.46 (15.16) |
938.36% | Details | |
| 8/8/2024 | LifeMD Inc | LFMD | Maintain | Buy (N/A) |
|
Details | ||
| 5/14/2024 | Veru, Inc. | VERU | New Coverage | Buy (N/A) |
1.33 (2.38) |
78.95% | Details | |
| 3/12/2024 | LifeMD Inc | LFMD | Maintain | Buy (N/A) |
|
Details | ||
| 12/12/2023 | Koru Medical Systems Inc. | KRMD | New Coverage | Buy (N/A) |
2.30 (4.11) |
78.7% | Details | |
| 12/1/2023 | Clearpoint Neuro Inc. | CLPT | New Coverage | Buy (N/A) |
5.76 (15.15) |
163.02% | Details | |
| 12/1/2023 | LifeMD Inc | LFMD | New Coverage | Buy (N/A) |
7.70 (4.15) |
-46.1% | Details |
